(Q35627607)

9 August 2017

1 reference

title

The emerging role of leukotriene modifiers in allergic rhinitis (English)

1 reference

9 August 2017

Mitchell H Grayson

1

1 reference

9 August 2017

Phillip E Korenblat

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2003

1 reference

Treatments in Respiratory Medicine

9 August 2017

published in

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

441-450

1 reference

Changing prevalence of allergic rhinitis and asthma

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Rhinitis and inhalant allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Second-generation antihistamines: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Pros and cons of the use of antihistamines in managing allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Persistent increase in plasma and urinary leukotrienes after acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Human mast cells secreting leukotriene C4 express the MRP1 gene-encoded conjugate export pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Characterization of the human cysteinyl leukotriene CysLT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Characterization of the human cysteinyl leukotriene 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Mediators and allergic inflammation of human airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Regulation of leukotrienes in the management of asthma: biology and clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Intranasal corticosteroids for allergic rhinitis: superior relief?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256671

21 January 2018

Identifiers

DOI

10.1007/BF03256671

1 reference

release_nby73kw4e5glxlf3kksfhfcrnq

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nby73kw4e5glxlf3kksfhfcrnq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference